Cognyte Software Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGNT research report →
Range $7.5 – $14
Price Chart
About the company
Cognyte Software Ltd. , established in Herzliya, Israel, in 2020, delivers sophisticated investigative analytics software to a global array of governmental organizations and commercial businesses. Its flagship offering, branded "Actionable Intelligence for a Safer World," is an open-source platform specifically engineered to expedite and bolster the efficacy of investigations.
- CEO
- Elad Sharon
- IPO
- 2021
- Employees
- 1,710
- HQ
- Herzliya, TA, IL
Get TickerSpark's AI analysis on CGNT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $652.67M
- P/E
- -2108.33
- Fwd P/E
- 18.74
- PEG
- 5.00
- P/S
- 1.55
- P/B
- 3.31
- EV/EBITDA
- 23.40
- Div Yield
- 0.00%
- Gross Margin
- 72.96%
- Op Margin
- 4.13%
- Net Margin
- -0.01%
- ROE
- -0.03%
- ROIC
- 2.28%
Latest fiscal year · YoY change
- Revenue
- $400.04M+14.1%
- Gross Profit
- $289.70M+17.3%
- Op Income
- $13.26M
- Net Income
- $-638,000+94.7%
- EPS
- $-0.01+94.9%
- OCF Growth
- -13.8%
- FCF Growth
- -11.6%
- 52W High
- $12.31
- 52W Low
- $6.29
- 50D MA
- $8.72
- 200D MA
- $8.86
- Beta
- 1.59
- RSI (14)
- 58
- Avg Volume
- 570.58K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Cognyte delivered double-digit revenue growth with much stronger profitability, while raising visibility on a growing software and recurring-revenue mix and reaffirming FY27/FY28 targets.· September 9, 2026
- Revenue rose 12% year over year to $109 million; non-GAAP EPS nearly doubled to $0.15 from $0.08.
- Total software revenue grew 20.9% to $100.8 million and recurring revenue grew 18.4% to $56.2 million, improving mix and visibility.
- Non-GAAP gross margin expanded to 73.7%, while non-GAAP operating income increased 52.5% to $12.2 million and adjusted EBITDA rose 35.7% to $14.9 million.
- Management said demand remains strong, with 14 new customers in H1 and on track for $20 million of signed deals in the U.S. this year.
- Full-year guidance was narrowed around an unchanged midpoint: revenue of about $448 million plus or minus 2%, with non-GAAP gross margin of about 73.5% and non-GAAP EPS of $0.47 at the midpoint.
Q2 revenue was $109 million, up 12% year over year. Total software revenue was $100.8 million, up 20.9%, and recurring revenue was $56.2 million, up 18.4%. Non-GAAP gross margin was 73.7%, up 154 basis points; non-GAAP gross profit was $80.5 million, up 14.4%; non-GAAP operating income was $12.2 million, up 52.5%; adjusted EBITDA was $14.9 million, up 35.7%; non-GAAP EPS was $0.15 versus $0.08 a year ago; GAAP diluted EPS was $0.06 versus $0.02. For the first half, revenue was $214.7 million, up 11.2%, total software revenue was $198.1 million, up 19.8%, recurring revenue was $108.1 million, up 14.2%, GAAP operating income was $9.1 million, up 85.1%, and non-GAAP operating income was $22.9 million, up 47.2%. Total RPO was $470.2 million, including $313.4 million of short-term RPO, and billings were $76.3 million. For FY27, management now expects revenue of approximately $448 million plus or minus 2% (around 12% growth at the midpoint), non-GAAP gross margin of approximately 73.5%, non-GAAP operating income of about $56 million, adjusted EBITDA of about $68 million, and non-GAAP EPS of $0.47 at the midpoint. Management also said Q3 revenue should be slightly higher than Q2, followed by sequential growth in Q4, and reiterated on track for the FY28 revenue target of $500 million.
Elad Sharon framed the quarter as evidence that the company’s strategy is working, with strong demand for AI-enabled, sovereign, mission-critical intelligence platforms. He emphasized that customers want tools they can trust, explain, and control, and said Cognite wins because it combines domain expertise, governance, and deployment under customer control. He also highlighted broad traction across new logos, expansions, and upgrades, including progress in U.S. federal, state and local, and international markets, while remaining confident in full-year and FY28 targets.
David Abadi focused on the improving business mix and operating leverage. He said software revenue made up more than 92% of total revenue in Q2, recurring revenue was 51.4% of revenue, and professional services fell to less than 8% from about 15% a year ago. He cited 73.7% gross margin, $102.2 million in cash, no debt, and $1.1 million of operating cash flow in Q2, while noting that FX and planned inventory investment affect cash generation. He also said the company repurchased about 1.5 million shares for $13.5 million in the first half and about $40.2 million since the buyback program began.
Analysts pressed on why revenue guidance remains modest relative to stronger bookings/RPO activity and whether the company is being conservative. Management responded that subscription adoption is improving quality and visibility but changes revenue timing, and that continued mix shift means reported growth can look lower than underlying demand. Questions also focused on the decline in total RPO and cash flow; management said the RPO decline reflects subscription cancellation rights, consumption of large multi-year support contracts, and renewal timing, while cash flow is being intentionally affected by higher inventory to support demand and manage supply-chain risk.
The bull case from this call is that demand appears healthy across geographies and customer segments, with strong new-logo activity, expansions, and U.S. federal opportunities moving into procurement. Management believes the shift to software and recurring revenue is making the business higher quality, more visible, and more profitable, while still supporting double-digit growth.
The main risks are that reported revenue growth may continue to lag underlying deal activity because of subscription-heavy mix and revenue recognition timing, and total RPO has been trending down. Cash generation is also being pressured by deliberate inventory builds and seasonal uses, and management would not quantify the near-term operating cash impact.```
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.8%
- Shares Outstanding
- 73.71M
- Float Shares
- 60.25M
of shares held by institutions
134 13F filers
Congressional trading
Senate and House stock disclosures for CGNT, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Edenbrook Capital, LLC | 7.26M | ▲ 257.63K |
| Value Base Ltd. | 6.45M | ▲ 214.00K |
| American Capital Management Inc | 6.18M | ▼ 312.64K |
| Neuberger Berman Group LLC | 5.51M | ▲ 190.59K |
| Topline Capital Management, LLC | 3.14M | ▼ 1.77M |
| Acadian Asset Management LLC | 2.92M | 0 |
| Y.D. More Investments Ltd | 1.85M | 0 |
| Samjo Management, LLC | 1.36M | ▲ 404.88K |
| Arrowstreet Capital, Limited Partnership | 997.55K | ▲ 329.89K |
| Ameriprise Financial Inc | 858.34K | ▲ 100.47K |
| Archon Capital Management LLC | 800.01K | ▲ 490.84K |
| Westerly Capital Management, LLC | 760.00K | ▼ 480.00K |
Held by 24 ETFs
Biggest fund positions in CGNT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 1, 26 | Philpott Adam Richard | other | 0 |
| Mar 16, 26 | Chouli Sharon | other | 0 |
| Mar 16, 26 | Cohen Gil | other | 0 |
| Mar 16, 26 | Nuri Efraim | other | 0 |
| Mar 16, 26 | Abadi David | other | 0 |
| Mar 16, 26 | Benjamini Nurit | other | 0 |
| Mar 16, 26 | O'Neill Matthew K | other | 0 |
| Mar 16, 26 | Shvili Ron | other | 0 |
| Mar 16, 26 | COHEN AVI | other | 0 |
| Mar 16, 26 | SHARIR DAFNA | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CGNT coverage
Recent articles, reports, and earnings notes.
No research on CGNT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CGNT report →Cognyte Renews $20+ Million Annual Agreement with Tier-1 National Security Agency
businesswire.com · Sep 30
Wall Street Analysts Believe Cognyte Software (CGNT) Could Rally 42.87%: Here's is How to Trade
zacks.com · Sep 23
Cognyte Signs ~$20 Million AI-Powered Expansion with EMEA National Security Customer
businesswire.com · Sep 22
3 Stocks to Buy on Broker Rating Upgrades as Fed Tightens Policy
zacks.com · Sep 17
Cognyte Secures ~$10 Million Contract with Long-Standing APAC National Security Customer
businesswire.com · Sep 15
Cognyte Software Ltd. (CGNT) Q2 2027 Earnings Call Transcript
seekingalpha.com · Sep 9
Cognyte Software Q2 Earnings Call Highlights
marketbeat.com · Sep 9
Cognyte Software Ltd. (CGNT) Q2 Earnings and Revenues Surpass Estimates
zacks.com · Sep 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.